We are live on
!
Find out more
ACM
Accipiter Capital Management Portfolio holdings
AUM
$124M
1-Year Est. Return
6.47%
This Fund
S&P 500
This Quarter
Est. Return
+13.82%
1 Year Est. Return
-6.47%
3 Year Est. Return
-55.92%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$78.5M
AUM Growth
-$30.4M
(-28%)
Cap. Flow
-$39.5M
Cap. Flow
% of AUM
-50.38%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
4
Closed
2
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GTS
Triple-S Management Corporation
GTS
|
+$12.5M |
| 2 |
Elevance Health
ELV
|
+$11.6M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$10.8M |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$3.52M |
| 5 |
KND
Kindred Healthcare
KND
|
+$974K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 54.68% |
| 2 | Healthcare | 27.5% |
| 3 | Technology | 17.82% |
Similar funds
ACM
MCM
TCM
ALIONA
HA
DFIG
PAM
KC
Accipiter Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Accipiter Capital Management held 9 positions worth $78.5M, down 28% from $109M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Accipiter Capital Management withdrew a net $39.5M in Q4 2013, closing 2 positions and reducing 4 holdings. Its most notable exit was Elevance Health, an estimated $11.6M position sold in full.
By sector, the portfolio is most concentrated in Financials at 55% of assets, up from 49% a quarter earlier, followed by Healthcare and Technology.
- Accipiter Capital Management's biggest Q4 2013 reduction was Triple-S Management Corporation, cutting an estimated $12.5M.
- Accipiter Capital Management fully exited Elevance Health in Q4 2013, selling an estimated $11.6M.
- Accipiter Capital Management's ten largest holdings make up 100% of its $78.5M portfolio in Q4 2013.
- Accipiter Capital Management opened 0 new positions and closed 2 in Q4 2013.
- Accipiter Capital Management's portfolio value fell 28% quarter-over-quarter to $78.5M.
Based on Accipiter Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.